Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSAP | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | USP7 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | ITGB3BP | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | NDC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | RNPS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | RAB11FIP5 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | FBXO32 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |